Search
Allurion Technologies Inc
ALURAdd to Watchlist
0.671USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
5.50MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
0.00%
1 Month
0.00%
6 Months
-53.72%
Year to Date
-45.44%
1 Year
-73.26%
Key Figures
--Open
0.000High
0.00Volume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
13.88%Turnover Ratio
0.671Prev. Close
0.000Low
0.00Turnover
LossP/E Static
-0.02P/B
0.00%Div Yield TTM
-148.98%ROA
4.18052wk High
0.21Volume Ratio
-26.15MNet Profit
1.70MShares
-295.4597EPS TTM
-0.36Beta
--ROE
0.65252wk Low
11.87%Amplitude
49.06%Gross Margin
5.50MMarket Cap
-5.84Reward/Risk
6.05%Risk Rate
TradingKey Stock Score of Allurion Technologies Inc
Currency: USD Updated: 2026-03-06Key Insights
Allurion Technologies Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is good.Its valuation is considered fairly valued, ranking 192 out of 475 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 5.50.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Allurion Technologies Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Allurion Technologies Inc Highlights
StrengthsRisks
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
Growing
The company is in a growing phase, with the latest annual income totaling USD 32.11M.
Overvalued
The company’s latest PE is -0.00, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 6.53M shares, increasing 33.90% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 88.65K shares of this stock.
Analyst Rating
Based on
1
analysts
Strong Buy
Current Rating
120.000
Target Price
+17781.09%
Upside Space
Allurion Technologies Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Allurion Technologies Inc Info
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
Ticker SymbolALUR
CompanyAllurion Technologies Inc
CEOGaur (Shantanu)
Websitehttps://www.allurion.com/en
Related Instruments
-0.36%
-0.48%
+1.62%
-4.90%
+2.99%
+3.24%
-1.64%
+4.66%
+2.84%
+1.03%
-1.13%
-1.87%
+2.17%
-6.65%
-1.78%
+2.42%
+1.76%
-0.16%
-1.72%
+0.34%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Allurion Technologies Inc (ALUR)?
The current price of Allurion Technologies Inc (ALUR) is 0.67.
What is the symbol of Allurion Technologies Inc?
The ticker symbol of Allurion Technologies Inc is ALUR.
What is the 52-week high of Allurion Technologies Inc?
The 52-week high of Allurion Technologies Inc is 4.18.
What is the 52-week low of Allurion Technologies Inc?
The 52-week low of Allurion Technologies Inc is 0.65.
What is the market capitalization of Allurion Technologies Inc?
The market capitalization of Allurion Technologies Inc is 5.50M.
Is Allurion Technologies Inc (ALUR) currently rated as Buy, Hold, or Sell?
According to analysts, Allurion Technologies Inc (ALUR) has an overall rating of STRONG BUY, with a price target of 120.00.
What is the Earnings Per Share (EPS TTM) of Allurion Technologies Inc (ALUR)?
The Earnings Per Share (EPS TTM) of Allurion Technologies Inc (ALUR) is -57.17.